The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) is a highly invasive and lethal neuroendocrine tumor. Antiangiogenic drugs have been reported in the treatment of SCLC. We aimed to provide a comprehensive evaluation of the impact of angiogenic inhibitors on SCLC survival using network meta‐analysis. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaoshun, Dong, Xiaoying, Young, Sylvia, Chen, Allen Menglin, Liu, Xiguang, Zheng, Zhouxia, Huang, Kailing, Lu, Di, Feng, Siyang, Morahan, Grant, Cai, Kaican
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792507/
https://www.ncbi.nlm.nih.gov/pubmed/31433125
http://dx.doi.org/10.1002/cam4.2462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792507/
https://www.ncbi.nlm.nih.gov/pubmed/31433125
http://dx.doi.org/10.1002/cam4.2462

Ejemplares similares